Literature DB >> 2041595

Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region.

P S Spencer1, G E Kisby, A C Ludolph.   

Abstract

The western Pacific parkinsonism-dementia and amyotrophic lateral sclerosis complex is a prototypical neurodegenerative disorder found among inhabitants of Guam, New Guinea (Irian Jaya, Indonesia) and Japan (Kii Peninsula, Honshu). Nonviral environmental factors peculiar to the affected populations seem to play a prominent etiologic role. Although cause-effect relationships cannot be established by epidemiologic studies alone, we have shown in all three affected population groups that individuals develop the amyotrophic lateral sclerosis variant of this disorder after heavy exposure to the raw or incompletely detoxified seed of neurotoxic cycad plants. Since long periods may elapse between cycad exposure and the appearance of neurological disease in humans, cycads may harbor a "slow toxin" that causes the postmitotic neuron to undergo slow irreversible degeneration. Two cycad neurotoxins are recognized, one of which (cycasin) is known to have long-latency effects (tumorigenesis) on mitotic neurons and replicating cells in other tissues. This paper explores the possible relationship between tumorigenesis and long-latency neurotoxicity, and discusses possible biologic markers of cycad exposure and subclinical neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041595     DOI: 10.1212/wnl.41.5_suppl_2.62

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Animal models of brain maldevelopment induced by cycad plant genotoxins.

Authors:  Glen E Kisby; Holly Moore; Peter S Spencer
Journal:  Birth Defects Res C Embryo Today       Date:  2013-12

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

3.  Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Authors:  Glen Kisby; Valerie Palmer; Mike Lasarev; Rebecca Fry; Mihail Iordanov; Eli Magun; Leona Samson; Peter Spencer
Journal:  Commun Integr Biol       Date:  2011-11-01

4.  PARADOXICAL RESPONSES TO NEUROTOXIC STERYL GLYCOSIDES: INSIGHTS FROM A CELLULAR MODEL OF ALSPDC.

Authors:  Christopher A Shaw; Steven Pelech; Philip T T Ly
Journal:  Neurobiol Lipids       Date:  2009-01-15

5.  Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.

Authors:  Paul Alan Cox; Sandra Anne Banack; Susan J Murch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

6.  The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.

Authors:  Glen E Kisby; Rebecca C Fry; Michael R Lasarev; Theodor K Bammler; Richard P Beyer; Mona Churchwell; Daniel R Doerge; Lisiane B Meira; Valerie S Palmer; Ana-Luiza Ramos-Crawford; Xuefeng Ren; Robert C Sullivan; Terrance J Kavanagh; Leona D Samson; Helmut Zarbl; Peter S Spencer
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 7.  Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Int J Environ Res Public Health       Date:  2011-09-29       Impact factor: 3.390

8.  Genotoxicants target distinct molecular networks in neonatal neurons.

Authors:  Glen E Kisby; Antoinette Olivas; Melissa Standley; Xinfang Lu; Patrick Pattee; Jean O'Malley; Xiaorong Li; Juan Muniz; Srinavasa R Nagalla
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

9.  Production of the neurotoxin BMAA by a marine cyanobacterium.

Authors:  Sandra Anne Banack; Holly E Johnson; Ran Cheng; Paul Alan Cox
Journal:  Mar Drugs       Date:  2007-12-06       Impact factor: 5.118

10.  BMAA inhibits nitrogen fixation in the cyanobacterium Nostoc sp. PCC 7120.

Authors:  Lotta Berntzon; Sven Erasmie; Narin Celepli; Johan Eriksson; Ulla Rasmussen; Birgitta Bergman
Journal:  Mar Drugs       Date:  2013-08-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.